“Oral … of BBR inhibited the NF-κB signal transduction pathway, reduced the … of pro-inflammatory cytokines [interleukin (IL)-1β, IL-6, interferon-γ , and tumor necrosis factor-α], promoted the expression of anti-inflammatory cytokines (IL-10 and transforming growth factor-β), and improved the terminal ileum tissue inflammation.”